UNH Quantitative Stock Analysis

Validea's report rates UnitedHealth Group (UNH) at 77% using its Martin Zweig Growth Investor model, which seeks growth stocks with accelerating earnings and sales, reasonable valuations, and low debt. This score places UNH just below the 80% threshold for 'some interest' in the model. While UNH passes key criteria like P/E ratio, sales growth, and long-term EPS growth, it did not meet certain earnings growth consistency metrics. The model itself is noteworthy, given Zweig's historical average return of 15.9% annually over 15 years.

Analysis

UnitedHealth Group (UNH) receives a score of 77% from Validea's Martin Zweig Growth Investor model, placing it just below the 80% threshold that indicates model interest. The analysis reveals a mixed but generally positive fundamental picture for the large-cap health insurance provider. UNH successfully passes several key criteria, including a reasonable P/E ratio, positive sales growth rate, strong current quarter earnings, and favorable long-term EPS growth and insider transaction trends. However, the model highlights specific weaknesses in its growth consistency. Notably, UNH fails on metrics concerning the relationship between revenue and EPS growth, the consistency of its earnings growth rate over the past several quarters, and its current EPS growth relative to its historical rate. This suggests that while the company demonstrates solid performance, it does not currently exhibit the persistent, accelerating earnings growth that is a core tenet of the Zweig strategy.

Key Decisions for Investors

• Investors should recognize that while UNH shows strong underlying fundamentals, it fails to meet the strict criteria for accelerating growth required by this specific model, suggesting it may be a stable performer rather than a high-momentum growth stock.
• For those considering a position, the key weaknesses to monitor in future earnings reports are the rate of earnings acceleration and the alignment between top-line revenue growth and bottom-line EPS growth.
• Given the positive signals on valuation, earnings persistence, and long-term growth, the stock may appeal more to long-term holders or GARP (Growth at a Reasonable Price) investors rather than pure momentum or aggressive growth strategists.